Impact Factor
3.16
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.11
117 total citations
h5-index
17
h5 depth signal
Cited share
81.6%
31 of 38
Total citations
117
Citation footprint
Metric signal
2.60
External metric anchor
Self-citation
12.0%
14 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
123
United States
26
Pakistan
9
United Kingdom
8
China
6
Citing Fields of Research
Drug Delivery Systems
126
Nanoparticles
35
Polymer & Macromolecule Science
25
Oncology
14
Immunology
12
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
458
Articles tracked across the journal lifetime
Indexed publication set
38
31 cited publications
Last 12 months
13
13.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
India
123 citing publications
Leading citing field
Drug Delivery Systems
126 citing publications
Latest tracked publication
1 January 2026
10 recent records available
Coverage & Indexing History
v1n1, 1984-
v1n1, 1984-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Broad Categories
Drug Therapy
Drug Delivery Systems
Polymer & Macromolecule Science
Musculoskeletal Disorders
Nanoparticles
Ophthalmology
MeSH Descriptors
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1615/critrevtherdrugcarriersyst.2026061018
Open DOI
Novel Formulations in Ocular Drug Delivery: A Comprehensive Review of Emerging Strategies and Therapeutic Advances
02
DOI 10.1615/critrevtherdrugcarriersyst.2026059584
Open DOI
Recent Advances in Biotechnological Products for the Targeted Delivery based Treatment of Inflammatory Bowel Diseases
03
DOI 10.1615/critrevtherdrugcarriersyst.2026055140
Open DOI
EARLY DETECTION OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT THROUGH ABNORMALITIES CLASSIFICATION USING DEEP LEARNING MODELS
04
DOI 10.1615/critrevtherdrugcarriersyst.2026058884
Open DOI
Patient-Centric Organ-on-Chip Models (OoCs): A Novel Framework for Drug Discovery and Disease Simulation
05
DOI 10.1615/critrevtherdrugcarriersyst.2026058501
Open DOI
Lipids as Pivotal Components in Nanocarrier Drug Delivery Systems: Evaluating Their Impact on Pharmacokinetics, Bioavailability, and Therapeutic Outcomes
06
DOI 10.1615/critrevtherdrugcarriersyst.2026058031
Open DOI
Stimuli-Responsive Wound Management: A Focus on Innovative pH-Driven Healing Systems
Wound healing, particularly in chronic and infected wounds, presents significant challenges due to persistent inflammation, microbial infections, and impaired tissue regeneration. Stimuli-responsive wound healing technologies offer promi...
07
DOI 10.1615/critrevtherdrugcarriersyst.2026058583
Open DOI
EMERGING ROLE OF RNA AS A THERAPEUTIC AGENT FOR HUMAN DISEASES: CURRENT TRENDS AND FUTURE DIRECTIONS
08
DOI 10.1615/critrevtherdrugcarriersyst.2026060256
Open DOI
Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases
Tyrosine kinase inhibitors (TKIs) represent a promising category of therapeutic agents for managing edema and neovascular eye diseases (NEDs) such as corneal neovascularization, proliferative diabetic retinopathy and neovascular age-rela...
09
DOI 10.1615/critrevtherdrugcarriersyst.2025057299
Open DOI
Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications
Curcumin is the main curcuminoid present in turmeric (Curcuma longa). Various studies have shown that curcumin has excellent antimicrobial properties and enhances the wound healing process. Herein, this study we have made an attempt to s...
10
DOI 10.1615/critrevtherdrugcarriersyst.2025056948
Open DOI
Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery
Transdermal drug delivery offers several benefits compared with oral delivery, including the bypassing of first-pass metabolism, the ability to target active ingredients for localized effects, and improved patient compliance. Nevertheles...
Bibliographical & Catalog Notes
On t.p. the registered trademark symbol "TM" is superscript following "reviews" in the title, 1985?- .
Vol. 4, no. 3 (1988) incorrectly dated as 1987.
Also issued online.
Vol. 1, no. 1 (1984)19911012 Notice not published Printed on acid-free paper